Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab
Public ClinicalTrials.gov record NCT02107131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of ReAding Speed, Contrast Sensitivity, and Work Productivity in Working Individuals With Diabetic Macular Edema Following Treatment With Intravitreal Ranibizumab
Study identification
- NCT ID
- NCT02107131
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- California Retina Consultants
- Other
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Intravitreal ranibizumab 0.3mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2015
- Primary completion
- May 14, 2017
- Completion
- May 14, 2017
- Last update posted
- Dec 18, 2018
2015 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Retina Consultants - Bakersfield | Bakersfield | California | 93039 | — |
| California Retina Consultants | Oxnard | California | 93454 | — |
| California Retina Consultants | Palmdale | California | 93551 | — |
| California Retina Consultants - Santa Barbara Office | Santa Barbara | California | 93103 | — |
| California Retina Consultants | Santa Maria | California | 93454 | — |
| California Retina Consultants | Visalia | California | 93277 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02107131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2018 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02107131 live on ClinicalTrials.gov.